Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Preclinical efficacy of prostaglandin analogues AL-12180 and AL-12182

May 13, 2004

Improvement of diabetes-induced retinal vascular abnormalities by AGIX-4207

May 13, 2004

Antibody against collagen IV cryptic epitope limits choroidal neovascularization in vivo

May 13, 2004

Visudyne launched in Japan

May 12, 2004

Promising results reported for AdPEDF.11 in choroidal neovascularization

May 12, 2004

Talaporfin reported to reduce choroidal leakage in ARMD

May 12, 2004

Dendrimer therapy effective against excessive post-eye surgery scarring

May 11, 2004

Novel PAF antagonist protects eyes against alkali and light-induced damage

May 11, 2004

Intravitreal pegaptanib reported safe and effective in ocular neovascularization disorders

May 10, 2004

Dose-dependent activity of EGT-001 in ocular angiogenesis model

May 7, 2004

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...